Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.
Pardi N, Hogan MJ, Naradikian MS, Parkhouse K, Cain DW, Jones L, Moody MA, Verkerke HP, Myles A, Willis E, LaBranche CC, Montefiori DC, Lobby JL, Saunders KO, Liao HX, Korber BT, Sutherland LL, Scearce RM, Hraber PT, Tombácz I, Muramatsu H, Ni H, Balikov DA, Li C, Mui BL, Tam YK, Krammer F, Karikó K, Polacino P, Eisenlohr LC, Madden TD, Hope MJ, Lewis MG, Lee KK, Hu SL, Hensley SE, Cancro MP, Haynes BF, Weissman D. Pardi N, et al. Among authors: verkerke hp. J Exp Med. 2018 Jun 4;215(6):1571-1588. doi: 10.1084/jem.20171450. Epub 2018 May 8. J Exp Med. 2018. PMID: 29739835 Free PMC article.
HIV-1 Neutralizing Antibodies with Limited Hypermutation from an Infant.
Simonich CA, Williams KL, Verkerke HP, Williams JA, Nduati R, Lee KK, Overbaugh J. Simonich CA, et al. Among authors: verkerke hp. Cell. 2016 Jun 30;166(1):77-87. doi: 10.1016/j.cell.2016.05.055. Epub 2016 Jun 23. Cell. 2016. PMID: 27345369 Free PMC article. Clinical Trial.
Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients.
Suthar MS, Zimmerman MG, Kauffman RC, Mantus G, Linderman SL, Hudson WH, Vanderheiden A, Nyhoff L, Davis CW, Adekunle O, Affer M, Sherman M, Reynolds S, Verkerke HP, Alter DN, Guarner J, Bryksin J, Horwath MC, Arthur CM, Saakadze N, Smith GH, Edupuganti S, Scherer EM, Hellmeister K, Cheng A, Morales JA, Neish AS, Stowell SR, Frank F, Ortlund E, Anderson EJ, Menachery VD, Rouphael N, Mehta AK, Stephens DS, Ahmed R, Roback JD, Wrammert J. Suthar MS, et al. Among authors: verkerke hp. Cell Rep Med. 2020 Jun 23;1(3):100040. doi: 10.1016/j.xcrm.2020.100040. Epub 2020 Jun 8. Cell Rep Med. 2020. PMID: 32835303 Free PMC article.
Maternal Antibody Response, Neutralizing Potency, and Placental Antibody Transfer After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
Joseph NT, Dude CM, Verkerke HP, Irby LS, Dunlop AL, Patel RM, Easley KA, Smith AK, Stowell SR, Jamieson DJ, Velu V, Badell ML. Joseph NT, et al. Among authors: verkerke hp. Obstet Gynecol. 2021 Aug 1;138(2):189-197. doi: 10.1097/AOG.0000000000004440. Obstet Gynecol. 2021. PMID: 33910220 Free PMC article.
Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibody.
Kumar S, Patel A, Lai L, Chakravarthy C, Valanparambil R, Reddy ES, Gottimukkala K, Davis-Gardner ME, Edara VV, Linderman S, Nayak K, Dixit K, Sharma P, Bajpai P, Singh V, Frank F, Cheedarla N, Verkerke HP, Neish AS, Roback JD, Mantus G, Goel PK, Rahi M, Davis CW, Wrammert J, Godbole S, Henry AR, Douek DC, Suthar MS, Ahmed R, Ortlund E, Sharma A, Murali-Krishna K, Chandele A. Kumar S, et al. Among authors: verkerke hp. Sci Adv. 2022 Oct 7;8(40):eadd2032. doi: 10.1126/sciadv.add2032. Epub 2022 Oct 5. Sci Adv. 2022. PMID: 36197988 Free PMC article.
Rapid generation of neutralizing antibody responses in COVID-19 patients.
Suthar MS, Zimmerman M, Kauffman R, Mantus G, Linderman S, Vanderheiden A, Nyhoff L, Davis C, Adekunle S, Affer M, Sherman M, Reynolds S, Verkerke H, Alter DN, Guarner J, Bryksin J, Horwath M, Arthur C, Saakadze N, Smith GH, Edupuganti S, Scherer EM, Hellmeister K, Cheng A, Morales JA, Neish AS, Stowell SR, Frank F, Ortlund E, Anderson E, Menachery V, Rouphael N, Metha A, Stephens DS, Ahmed R, Roback J, Wrammert J. Suthar MS, et al. medRxiv [Preprint]. 2020 May 8:2020.05.03.20084442. doi: 10.1101/2020.05.03.20084442. medRxiv. 2020. PMID: 32511565 Free PMC article. Updated. Preprint.
Comparison of Antibody Class-Specific SARS-CoV-2 Serologies for the Diagnosis of Acute COVID-19.
Verkerke H, Horwath M, Saeedi B, Boyer D, Allen JW, Owens J, Arthur CM, Nakahara H, Rha J, Patel K, Wu SC, Paul A, Yasin N, Wang J, Shin S, Brown D, Normile K, Cole L, Meyers M, Lin H, Woods E, Isaac J, Broder K, Wade J, Kauffman RC, Patel R, Josephson CD, Reynolds S, Sherman M, Wrammert J, Alter D, Guarner J, Roback JD, Neish A, Stowell SR. Verkerke H, et al. J Clin Microbiol. 2021 Mar 19;59(4):e02026-20. doi: 10.1128/JCM.02026-20. Print 2021 Mar 19. J Clin Microbiol. 2021. PMID: 33468605 Free PMC article.
Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma.
Nooka AK, Shanmugasundaram U, Cheedarla N, Verkerke H, Edara VV, Valanparambil R, Kaufman JL, Hofmeister CC, Joseph NS, Lonial S, Azeem M, Manalo J, Switchenko JM, Chang A, Linderman SL, Roback JD, Dhodapkar KM, Ahmed R, Suthar MS, Neish AS, Dhodapkar MV. Nooka AK, et al. J Clin Oncol. 2022 Sep 10;40(26):3057-3064. doi: 10.1200/JCO.21.02257. Epub 2022 Mar 8. J Clin Oncol. 2022. PMID: 35259002 Free PMC article.
46 results